| Literature DB >> 31523358 |
Aryan Rafiee Zadeh1, Keyvan Ghadimi1, Akram Ataei2, Mozhde Askari1, Neda Sheikhinia2, Nooshin Tavoosi3, Masih Falahatian1.
Abstract
Multiple Sclerosis (MS) is an autoimmune, inflammatory disease of the central nervous system (CNS) mostly affecting young adults. The exact mechanism and pathogenesis of MS remain still undiscovered but there have been useful treatments with different efficacy rates. Most of these therapies are divided into the first line, second line and third line, impact on the immune system and immune cells. These drugs are approved to be useful in MS, but like any other therapies, adverse effects (AE) are associated with these drugs. In this review, we continue the survey over mechanisms of actions and AEs of MS drugs. Physicians must be aware of such AEs and complications to choose the best drug for each patient.Entities:
Keywords: Mechanism; adverse effect; drug; multiple sclerosis
Year: 2019 PMID: 31523358 PMCID: PMC6737425
Source DB: PubMed Journal: Int J Physiol Pathophysiol Pharmacol ISSN: 1944-8171